The role of the immune response in HER2+ disease: Is it relevant for patient care?

Date 10 October 2016
Event ESMO 2016 Congress
Session HER2+ advanced breast cancer: A few more questions and many more answers
Topics Immunotherapy
Breast Cancer
Presenter Sherene Loi
Authors S. Loi
  • Division Of Cancer Medicine, Peter MacCallum Cancer Center, 3000 - Melbourne/AU